A lot of international bodies are working on this. For example, under Codex Alimentarius there's the agricultural biotechnology committee. They've developed a set of guidelines and standards on how to evaluate biotechnology products. They've also developed a low-level presence annex, and this defines some of the information that needs to be developed and looked at to come up with an approval on low-level presence. These are countries from around the world.
With the Convention on Biological Diversity, the interesting thing I heard from my colleagues who were just at the meeting in Nagoya, Japan, was they talked about this year being a game-changer. This year countries around the world discussed how to make it work. It was no longer that this is not a product we don't want to bring forward; it's that biotechnology can bring solutions. So how are we going to make it work?
Another thing I want to bring up is the transboundary movement on living modified organisms, or LMOs. The industry brought together something they're calling the compact. They believe the science behind the products they've brought forward is safe, the products are safe, and they're willing to stand behind that. The development of the compact is a very clearly defined and efficient process whereby countries can bring forward claims of damage to biological diversity.